Editas Medicine (EDIT) Change in Account Payables (2015 - 2025)
Editas Medicine (EDIT) posted quarterly Change in Account Payables of -$3.6 million for Q3 2025, down 183.97% year-over-year from $4.2 million in Q3 2024, and down 383.07% quarter-over-quarter from $1.3 million in Q2 2025.
Editas Medicine (EDIT) Change in Account Payables (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has reported Change in Account Payables for 11 consecutive years, with -$3.6 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Change in Account Payables fell 183.97% year-over-year to -$3.6 million; the TTM figure through Sep 2025 stood at -$9.3 million (down 540.25% YoY), while the FY2024 annual figure was -$2.3 million, down 53.22% from the prior year.
- Change in Account Payables slipped to -$3.6 million in Q3 2025 per EDIT's latest filing, from $1.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $7.4 million in Q2 2024 and bottomed at -$7.0 million in Q4 2024.
- Historically, Change in Account Payables has averaged -$151526.3 across 5 years, with a median of -$229000.0 in 2022.
- Annual changes were most pronounced in 2023 — Change in Account Payables sank 196.29% — and 2024, when it soared 1161.95%.
- Editas Medicine's Change in Account Payables stood at $1.8 million in 2021, then soared by 46.49% to $2.7 million in 2022, then tumbled by 196.29% to -$2.6 million in 2023, then plunged by 169.81% to -$7.0 million in 2024, then soared by 49.12% to -$3.6 million in 2025.
- Business Quant data shows EDIT's Change in Account Payables at -$3.6 million in Q3 2025, $1.3 million in Q2 2025, and -$27000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -66.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.03 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 37.53 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 520,137.79 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Editas Medicine | 263.01 Mn | 116.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -3.56 Mn |
| Sep 30, 2025 | -3.56 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | -27,000.00 |
| Mar 31, 2025 | -27,000.00 |
| Dec 31, 2024 | -7.00 Mn |
| Dec 31, 2024 | -7.00 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Sep 30, 2024 | -1.25 Mn |
| Jun 30, 2024 | 7.42 Mn |
| Jun 30, 2024 | 7.42 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Mar 31, 2024 | -1.46 Mn |
| Dec 31, 2023 | -2.59 Mn |
| Dec 31, 2023 | -2.59 Mn |
| Sep 30, 2023 | 2.36 Mn |
| Sep 30, 2023 | 2.36 Mn |
| Jun 30, 2023 | -699,000.00 |
| Jun 30, 2023 | -699,000.00 |